» Articles » PMID: 33014966

Bacterial Genome Wide Association Studies (bGWAS) and Transcriptomics Identifies Cryptic Antimicrobial Resistance Mechanisms in

Overview
Specialty Public Health
Date 2020 Oct 5
PMID 33014966
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Antimicrobial resistance (AMR) in the nosocomial pathogen, , is becoming a serious public health threat. While some mechanisms of AMR have been reported, understanding novel mechanisms of resistance is critical for identifying emerging resistance. One of the first steps in identifying novel AMR mechanisms is performing genotype/phenotype association studies; however, performing these studies is complicated by the plastic nature of the pan-genome. In this study, we compared the antibiograms of 12 antimicrobials associated with multiple drug families for 84 isolates, many isolated in Arizona, USA. screening of these genomes for known AMR mechanisms failed to identify clear correlations for most drugs. We then performed a bacterial genome wide association study (bGWAS) looking for associations between all possible 21-mers; this approach generally failed to identify mechanisms that explained the resistance phenotype. In order to decrease the genomic noise associated with population stratification, we compared four phylogenetically-related pairs of isolates with differing susceptibility profiles. RNA-Sequencing (RNA-Seq) was performed on paired isolates and differentially-expressed genes were identified. In these isolate pairs, five different potential mechanisms were identified, highlighting the difficulty of broad AMR surveillance in this species. To verify and validate differential expression, amplicon sequencing was performed. These results suggest that a diagnostic platform based on gene expression rather than genomics alone may be beneficial in certain surveillance efforts. The implementation of such advanced diagnostics coupled with increased AMR surveillance will potentially improve infection treatment and patient outcomes.

Citing Articles

Aminoglycoside resistance genes in early members of the Acinetobacter baumannii ST78A (SMAL, Italian clone) reside in an IS26-bounded island in the chromosome.

Harmer C, Cahill S, Kenyon J, Hall R J Antimicrob Chemother. 2024; 79(5):1014-1018.

PMID: 38530861 PMC: 11062947. DOI: 10.1093/jac/dkae064.


Within-species variability of antibiotic interactions in Gram-negative bacteria.

Tang P, Sanchez-Hevia D, Westhoff S, Fatsis-Kavalopoulos N, Andersson D mBio. 2024; 15(3):e0019624.

PMID: 38391196 PMC: 10936430. DOI: 10.1128/mbio.00196-24.


Genome-Wide Association Studies (GWAS) Approaches for the Detection of Genetic Variants Associated with Antibiotic Resistance: A Systematic Review.

Mosquera-Rendon J, Moreno-Herrera C, Robledo J, Hurtado-Paez U Microorganisms. 2023; 11(12).

PMID: 38138010 PMC: 10745584. DOI: 10.3390/microorganisms11122866.


Genetic variation and function: revealing potential factors associated with microbial phenotypes.

Liu X, Ma Y, Wang J Biophys Rep. 2023; 7(2):111-126.

PMID: 37288143 PMC: 10235906. DOI: 10.52601/bpr.2021.200040.


Making sense of drug-efflux transporters in the physiological environment.

Zgurskaya H, Adamiak J, Leus I Curr Opin Microbiol. 2022; 69:102179.

PMID: 35882103 PMC: 9942525. DOI: 10.1016/j.mib.2022.102179.


References
1.
Poole K . Bacterial stress responses as determinants of antimicrobial resistance. J Antimicrob Chemother. 2012; 67(9):2069-89. DOI: 10.1093/jac/dks196. View

2.
Rossjohn J, Polekhina G, Feil S, Allocati N, Masulli M, Di Illio C . A mixed disulfide bond in bacterial glutathione transferase: functional and evolutionary implications. Structure. 1998; 6(6):721-34. DOI: 10.1016/s0969-2126(98)00074-4. View

3.
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A . The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20(9):1297-303. PMC: 2928508. DOI: 10.1101/gr.107524.110. View

4.
Choi J, Kim C, Park Y, Yoon H, Shin S, Kim Y . Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia. Yonsei Med J. 2006; 47(1):63-9. PMC: 2687582. DOI: 10.3349/ymj.2006.47.1.63. View

5.
Afzal-Shah M, Woodford N, Livermore D . Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother. 2001; 45(2):583-8. PMC: 90330. DOI: 10.1128/AAC.45.2.583-588.2001. View